Diana Hausman is Chief Medical Officer at Zymeworks Inc. (ZYME). They have made 6 open-market trades across 4 companies since 2015, most recently 2025-07-02.
CIK 0001563992
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $47K since 2015, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMRX | BUY | 2025-07-02 | 2025-07-07 | $3.61 | $20K | +4.5% | -14.5% | +52.6% |
| ZNTL | SELL | 2024-05-09 | 2024-05-09 | $12.62 | $42K | -7.3% | -16.3% | -73.7% |
| ZYME | SELL · 10b5-1 | 2021-03-10 | 2021-03-12 | $34.95 | $37K | -10.4% | -19.6% | +6.2% |
| ZYME | SELL | 2020-12-04 | 2020-12-04 | $55.12 | $665K | -6.5% | -10.8% | -41.8% |
| ZYME | SELL | 2020-12-01 | 2020-12-03 | $55.19 | $2.1M | -6.3% | -10.9% | -37.8% |
| ZYME | SELL | 2020-09-14 | 2020-09-16 | $45.00 | $1.8M | +10.1% | +12.5% | +26.1% |
| ONTY | BUY | 2015-06-01 | 2015-06-03 | $4.65 | $27K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.